# US 2010/0167262 A1 · Method and reagent for the specific identification and quantification of one or more proteins in a sample using in particular inductively coupled plasma-mass spectrometry

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167262 A1
- Document ID: US20100167262A1
- Status: Published application
- Kind: A1
- Application number: 12/297,092
- Filed: 2007-04-13
- Published: 2010-07-01
- Earliest claimed: 2006-04-14
- Assignees: Proteome Factory AG; Humboldt-Universitaet zu Berlin
- Inventors: Michael Linscheid; Stefan Pieper; Christian Scheler; Robert Ahrends
- Web page: https://patentgrep.com/patent/US20100167262A1

## CPC

- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a method for the identification and quantification of one or more biomolecules in a sample containing a mixture of substances, wherein said method comprises the steps of, a) providing a sample which contains one or more biomolecules, b) providing a reagent for the analysis of biomolecules according to Formula I (A-Y-PRG) wherein, A may be present or absent and when A is present, A is H or constitutes at least one functional group for the reversible, covalent or non-covalent binding to a support material, whereby Y is a group comprising at least one chelate function for metals, preferable low in isotopes, and whereby PRG is a reactive group for the selective binding of biomolecules to be analyzed, c) coupling the one or more biomolecules from step a) to the reagent of step b), d) selecting the one or more biomolecules labeled in step c) under the employment of a functional group for the reversible, covalent or non-covalent binding to a support material and removal of the one or more unbound biomolecules, wherein (d) optionally comprises releasing the bound biomolecules from the support material and the elution from the matrix; and f) detecting and identifying the one or more labeled biomolecules by means of Inductively Coupled Plasma-Mass Spectrometry (ICP-MS), wherein f) optionally comprises cleaving the one or more biomolecules in said sample wherein, said cleaving may be performed (i) before coupling of the reagent PRG or (ii) after coupling.

## Claims

### Claim 1

Method for the identification and quantification of one or more biomolecules in a sample containing a mixture of substances, wherein said method comprises the steps of:
a) providing a sample which contains one or more biomolecules;
b) providing a reagent for the analysis of biomolecules according to Formula I;
A-Y-PRG Formula I
wherein, A may be present or absent and when A is present, A is H or constitutes at least one functional group for the reversible, covalent or non-covalent binding to a support material, whereby Y is a group comprising at least one chelate function for metals, preferable low in isotopes, and whereby PRG is a reactive group for the selective binding of biomolecules to be analyzed;
c) coupling the one or more biomolecules from step a) to the reagent of step b);
d) selecting the one or more biomolecules labeled in step c) under the employment of a functional group for the reversible, covalent or non-covalent binding to a support material and removal of the one or more unbound biomolecules, wherein (d) optionally comprises releasing the bound biomolecules from the support material and the elution from the matrix; and
f) detecting and identifying the one or more labeled biomolecules by means of Inductively Coupled Plasma-Mass Spectrometry (IC PMS), wherein f) optionally comprises cleaving the one or more biomolecules in said sample wherein, said cleaving may be performed (i) before coupling of the reagent PRG or (ii) after coupling.

### Claim 2 (depends on 1)

Method according to claim 1, wherein prior to the detecting step f), a fractionation step is included and the means of fractionation is selected from the group of (i) fractionation based on chemical properties of the sample and/or the one or more labeled biomolecules, (ii) physical properties of the sample and/or the one or more labeled biomolecules, (iii) both, chemical and physical properties of the sample and/or the one or more labeled biomolecules.

### Claim 3 (depends on 2)

Method according to claim 2, wherein the means of fractionation is selected from the group of HPLC, LC, FPLC, spin column separation, affinity chromatography, size exclusion chromatography, hydrophobic interaction chromatography, ion exchange chromatography, chromatofocussing, immuno precipitation, gel based methods, 2DGE, electrophoresis, breakable PAGE gels, isoelectric focussing, free-flow electrophoresis, capillary electrophoresis and separation by centrifugation or ultracentrifugation.

### Claim 4 (depends on 1)

Method according to claim 1, wherein the fractions are further analyzed by additional chemical and biological methods, fractionation, chemical or enzymatical cleavage, fractionation and mass spectrometric methods for quantitation and identification of biomolecules present in the fractions.

### Claim 5 (depends on 1)

Method according to claim 1, wherein arrangement of the groups A, X and PRG is interchanged.

### Claim 6 (depends on 1)

Method according to claim 1, wherein the one or more biomolecules in the sample are selected from the group of, (a) one or more known biomolecules and wherein the reagent according to Formula I is bound to said one or more known biomolecules, (b) one or more unknown biomolecules and wherein the reagent according to Formula I is bound to said one or more unknown biomolecules.

### Claim 7 (depends on 6)

Method according to claim 6, wherein, the known and unknown biomolecule is selected from the group comprising a pyrogen, a pharmaceutical compound, a pharmaceutical lead compound, an allergen, an autoimmunogen, a toxin, a polyclonal antibody, a monoclonal antibody, an antigen, a lipid, a carbohydrate, a peptide, a protein, a protein complex, an amino acid, a fatty acid, a nucleotide DNA, RNA, PNA, siRNA and microRNA.

### Claim 8 (depends on 1)

Method according to claim 1, wherein, the one or more biomolecules present are quantified with the aid of an internal standard, wherein the internal standard is a solution containing known metal concentrations of at least one or more metals and/or the internal standard consists of one or more biomolecules of known concentration which are labelled by one or more reagents according to the general Formula I
A-Y-PRG Formula I
whereby, A may be present or absent and when A is present, A is H or constitutes at least one functional group for the reversible, covalent or non-covalent binding to a support material, whereby Y is a group comprising at least one chelate function for metals, preferable low in isotopes, and whereby PRG is a reactive group for the selective binding of biomolecules to be analyzed;

### Claim 9 (depends on 1)

Method according to claim 1, wherein the one or more biomolecules are present in the sample at an amount of less than 1 millimol, or less than 1 micromol or less than 1 nanomol, or less than 1 picomol, or less than 1 femtomol, or less than 1 attomol or at an amount less than 1 milligram, or less than 1 microgram or less than 1 nanogram, or less than 1 picogram, or less than 1 femtogram, or less than 1 attogram.

### Claim 10 (depends on 1)

Method according to claim 1, wherein the dynamic range of quantities measured in the reaction is higher than 106, higher than 107, higher than 108, higher than 109, higher than 1010, or higher than 1011.

### Claim 11 (depends on 10)

Method according to claim 10, wherein the dynamic range of the quantities of biomolecules analyzed can vary between 100 and 109 in concentration and if two or more biomolecules are analyzed their respective concentrations may vary between 100 and 109 in concentration.

### Claim 12 (depends on 1)

The method according to claim 1 for the detection of peptides in a biological sample and/or for determining the relative and/or absolute expression of proteins in a protein-containing sample.

### Claim 13 (depends on 1)

The method according to claim 1 for performing quality control assays during or after production processes in the field of chemistry, food production, pharmacy, production of recombinant proteins and peptides, amino acids, carbohydrates, lipids, fatty acids and diagnostic assays.
